Cognitive effects of risperidone in children with autism and irritable behavior

Journal of Child and Adolescent Psychopharmacology

Volumn 18, Issue 3, 2008, Pages 227-236

  Aman, Michael G ^a   Hollway, Jill A ^a   McDougle, Christopher J ^b   Scahill, Lawrence ^c   Tierney, Elaine ^d   McCracken, James T ^e   Arnold, L Eugene ^a   Vitiello, Benedetto ^f   Ritz, Louise ^f   Gavaletz, Allison ^c   Cronin, Pegeen ^e   Swiezy, Naomi ^b   Wheeler, Courtney ^d   Koenig, Kathleen ^c   Ghuman, Jaswinder K ^d   Posey, David J ^b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b INDIANA UNIVERSITY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RISPERIDONE;

ADOLESCENT; ARTICLE; ATTENTION; AUTISM; BEHAVIOR DISORDER; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE BLIND PROCEDURE; EYE HAND COORDINATION; FEMALE; HUMAN; IRRITABILITY; LEARNING; MALE; MATHEMATICS; MULTICENTER STUDY; PERFORMANCE MEASUREMENT SYSTEM; RANDOMIZED CONTROLLED TRIAL; SHORT TERM MEMORY; SPATIAL MEMORY; VERBAL MEMORY; WORD RECOGNITION; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; PHYSIOLOGY; PRESCHOOL CHILD; PSYCHOLOGICAL ASPECT; PSYCHOMOTOR PERFORMANCE;

ADOLESCENT; AUTISTIC DISORDER; CHILD; CHILD BEHAVIOR DISORDERS; CHILD, PRESCHOOL; COGNITION; COGNITION DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IRRITABLE MOOD; MALE; PSYCHOMOTOR PERFORMANCE; RISPERIDONE;

EID: 57749185836     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2007.0133     Document Type: Article

References (32)

1. Aman, MG: Drugs and learning in mentally retarded persons. In G. D. Burrows & J. S. Werry (Eds.), Advances in Human Psychopharmacology (Vol. 3, pp.121-163). Greenwich, Ct.: JAI Press, 1984.
2. Aman MG, Arnold L, McDougle CJ, Vitiello B, Scahill L, Davies M, McCracken JT, Tierney E, Nash PL, Posey DJ, Chuang S, Martin A, Shah B, Gonzalez NM, Swiezy NB, Ritz L, Koenig K, McGough J, Ghuman JK, Lindsay RL: Acute and long-term safety and tolerability of risperidone in children with autism. J Child Adolesc Psychopharmacol 15:869-884, 2005.
3. Aman MG, Hollway JA, Leone S, Masty J, Lindsay R Nash P, Arnold LE: Effects of risperidone on cognitive-motor performance and motor movements in chronically medicated children. Res Dev Disabil. (in press).
4. Aman MG, Marks RE, Turbott SH, Wilsher CP, Werry SN: Methylphenidate and thioridazine in the treatment of intellectually subaverage children: Effects on cognitive-motor performance. J Am Acad Child Adolesc Psychiatry 30:816-824, 1990.
5. Aman MG, Pearson DA: Monitoring and measuring drug effects. II. Behavioral, emotional, and cognitive effects. In JS Werry, MG Aman (eds.) Practitioner's Guide to Psychoactive Drugs for Children and Adolescents (2nd ed). New York: Plenum Press, 1999. pp. 99-164.
6. Aman MG, Singh NN: Aberrant Behavior Checklist Manual. East Aurora, NY: Slosson Educational Publications, 1994.
7. Arnold LE, Aman MG, Martin A, Collier-Crespin A, Vitiello B, Tierney E, Asarnow R, Bell-Bradshaw F, Freeman BJ, Gates-Ulanet P, Klin A, McCracken JT, McDougle CJ, McGough JJ, Posey DJ, Scahill L, Swiezy NB, Ritz L, Volkmar F: Assessment in multisite randomized clinical trials of patients with autistic disorder: The Autism RUPP Network. J Autism Dev Disord 30:99-111, 2000.
8. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington, D.C.: American Psychiatric Association, 1994.
9. Bilder RM, Goldman RS, Volavka J, Czobor P, Hoptman M, Sheitman B, Lindenmayer J, Citrome L, McEnvoy J, Kunz M, Chakos M, Cooper TB, Horowitz TL, Lieberman JA: Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry. 159:1018-1028, 2002.
10. Delis DC, Kramer JH, Kaplan E, Ober BA: California Verbal Learning Test Manual - Children's Version. San Antonio, TX: The Psychological Corporation, 1994.
11. Dunn LM, Dunn LM, Robertson GJ, Eisenberg JL: Peabody Picture Vocabulary Test - Revised (PPVT-R). Circle Pines, MN: American Guidance Service, 1981.
12. Ernst M, Malone RP, Rowan AB, George R, Gonzalez NM, Silva RR: Antipsychotics (neuroleptics). In JS Werry, MG Aman (eds.). Practitioner's Guide to Psychoactive Drugs for Children and Adolescents. New York: Plenum, 1988. Pp. 297-327.
13. Günther T, Herpertz-Dahlmann B, Jolles J, Konrad K: The influence of risperidone on attentional functions in children and adolescents with attention-deficit/hyperactivity disorder and co-morbid disruptive behavior disorder. J Child Adolesc Psychopharmacol. 16:725-735, 2006.
14. Handen BL, Broaux AM, Gosling A, Ploof DL, Feldman H: The efficacy of methylphenidate among mentally retarded children with attention-deficit/ hyperactivity disorder. Pediatrics. 86: 922-930, 1990.
15. Keefe RS, Silva SG, Perkins DO, Lieberman JA: The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: A review and meta-analysis. Schizophr Bull. 25:201-222, 1999.
16. Keefe RS, Lees-Roitman SE, Dupre RL: Performance of patients with schizophrenia on a pen and paper visuospatial working memory task with short delay. Schizophr Res. 26:9-14, 1997.
17. Keppel G, Wickens TD: Design and Analysis: A Researcher's Handbook (4th. ed.). New Jersey: Prentice Hall, 2004.
18. Lord C, Rutter M. LeCouteur A: Autism diagnostic interview-revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord: 24:659-685, 2004.
19. McGurk SR, Carter CC, Goldman R, Green MF, Marder SR, Haiyi X, Schooler NR, Kane JM: The effects of clozapine and risperidone on spatial working memory in schizophrenia. Am J Psychiatry. 162:1013-1016, 2005.
20. National Institute of Mental Health: CGI (Clinical Global Impressions Scale). Psychopharmacol Bull. 21:839-844, 1985.
21. Pandina GJ, Bilder R, Harvey PD, Keefe RSE, Aman MG, Gharabawi G: Risperidone and cognitive function in children with disruptive behavior disorders. Biol Psychiatry, 62, 226-234, 2007.
22. Purdon SE. Cognitive improvement in schizophrenia with novel antipsychotic medications. Schizophr Res. 35:S51-S60, 1999.
23. Reilly JL, Harris MS, Keshavan MS, Sweeney JA: Adverse effects of risperidone on spatial working memory in first-episode schizophrenia. Arch Gen Psychiatry. 63:1189-1197, 2006.
24. Research Units on Pediatric Psychopharmacology Autism Network: Risperidone in children with autism and serious behavioral problems. N Engl J Med. 347:314-321, 2002.
25. Scahill L, McCracken J, McDougle CJ, Aman MG, Arnold LE, Tierney E, Cronin P, Davies M, Ghuman J, Gonzalez N, Koenig K, Lindsay R, Martin A, McGough J, Posey DJ, Swiezy N, Volkmar F, Ritz L, Vitiello B: Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism. J Child Adolesc Psychopharmacol. 11:377-388, 2001.
26. SPSS: SPSS 13.0 for Windows. Chicago: SPSS, 2003.
27. Stip E, Chouinard S, Boulay LJ: On the trail of a cognitive enhancer for the treatment of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 29:219-232, 2005.
28. Tiflin J, Asher EJ: The Purdue Pegboard: Norms and studies of reliability and validity. J Appl Psychology. 32:234-247, 1948.
29. Tiflin J: Purdue Pegboard Examiner Manual. Chicago: Science Research Associates, 1968.
30. Troost PW, Althaus M, Lahius BE, Buitelaar JK, Minderaa RB, Hoekstra PJ: Neuropsychological effects of risperidone in children with pervasive developmental disorders: A blinded discontinuation study. J Child Adolesc Psychopharmacol. 16:561-573, 2006.
31. Wilkinson GS: Wide Range Achievement Test - Third Edition. Administration Manual. Wilmington DE: Wide Range, Inc, 1993.
32. Yoo HJ, Williams DC, Napolitano DA, Peyton RT, Baer DM, Schroeder SR: Rate-decreasing effects of the atypical neuroleptic risperidone attenuated by conditions of reinforcement in a woman with mental retardation. J Appl Behav Anal. 36:245-248, 2003.